Christopher Gill

Professor of Global Health at Boston University

Schools

  • Boston University

Links

Biography

Boston University

Dr. Gill is an infectious disease specialist by training. From 2002-2008 he was a faculty member of the Department of Global Health at Boston University School of Public Health, engaged in a wide variety of clinical trials and investigations. His research interests have focused on child survival, and include diarrheal diseases, tuberculosis, pneumococcal and meningococcal disease, adherence to HIV medications, and neonatal survival.

He was the principal investigator of the Lufwanyama Neonatal Survival Project in Northern Zambia (LUNESP), a prospective, cluster randomized and controlled effectiveness study designed to determine whether training traditional birth attendants to manage several common perinatal conditions could reduce neonatal mortality in the setting of a resource poor country with limited access to healthcare. The results demonstrated that training traditional birth attendants in neonatal resuscitation skills significantly reduces neonatal mortality by approximately 50%. From 2008-end of 2010 he was the Director of the Meningitis ACWY conjugate vaccine clinical trials group at Novartis Vaccines. There he was responsible for the design, implementation and analysis of Phase IIb, III and IV clinical trials in support of the vaccine, and played a key role in licensing this new vaccine in over 33 countries around the world, including the US. In 2011, he rejoined the faculty at the BU Center for Global Health and Development and the BU School of Public Health. Christopher Gill has an MD from the University of Massachusetts Medical School and an MS from Tufts-Sackler School of Graduate Biomedical Studies.

Read about executive education

Cases

Ebola Study Shows How ‘Superspreaders’ Can Prolong An Outbreak

February 22, 2017

Huffington Post Christopher Gill, School of Public Health Disease “superspreaders” may have played a major role in the spread of the Ebola virus during the 2014 outbreak in West Africa, according to a new statistical analysis published in Proceedings of the National Academy of Sciences… Expert quote: ““[Ebola virus] is an interesting example because it […]

View full article

US Toughens Rules for Clinical-Trial Transparency

September 19, 2016

Scientific American Christopher Gill, School of Medicine The disappointing results of clinical trials will no longer be able to languish unpublished, thanks to rules released on September 16 by the U.S. Department of Health and Human Services (HHS) and the U.S. National Institutes of Health (NIH). Expert quote: “From the perspective of consumers and science, […]

View full article

If we want medicine to be evidence-based, what should we think when the evidence doesn’t agree?

January 15, 2016

The Conversation US By Christopher Gill, School of Public Health To understand if a new treatment for an illness is really better than older treatments, doctors and researchers look to the best available evidence. Health professionals want a “last word” in evidence to settle questions about what the best modes of treatment are… View full […]

View full article

Unpredictable virus means no one can promise last year’s flu season won’t happen again

October 3, 2015

Modern Healthcare Christopher Gill, School of Public Health After last year’s devastating flu season, which hospitalized the largest number of seniors in the U.S. ever recorded, public health officials have had to assure providers that the flu vaccines they’re getting right about now will work… Expert quote: “We’re committing to which flu strains we’re going […]

View full article

Are Ultra-Orthodox Turning Away From Vaccination?

September 17, 2014

The Jewish Daily Forward Christopher Gill, School of Public Health, Center for Global Health & Development A prominent ultra-Orthodox rabbi has drawn criticism for calling vaccines a “hoax,” but his beliefs are not uncommon in Orthodox circles… Expert quote: “If a population were entirely self-contained, like living on an island with a force field around it, […]

View full article

Parents of ailing boys go over FDA

April 2, 2014

Boston Herald Christopher Gill, School of Public Health, Center for Global Health & Development Parents desperate to give their children a fighting chance against a deadly, muscle-destroying disease are doing an end run around the FDA and pleading directly with the White House to push regulators to approve a breakthrough drug that could transform the […]

View full article

Lancet: How To Save A Couple Of Million Small Children’s Lives A Year

April 12, 2013

WBUR “CommonHealth” Christopher Gill, School of Public Health, Center for Global Health & Development We’ve made so much progress on AIDS in Africa; now it’s time to tackle the world’s biggest child-killers, pneumonia and diarrhea… View full article

View full article

How to save two million lives

April 11, 2013

The Guardian Christopher Gill, School of Public Health, Center for Global Health & Development A global plan to save the lives of the two million children who die from pneumonia and diarrhea  diarrhoea every year – the most common causes of death in children on the planet – is launched today and deserving of much […]

View full article

Other experts

Kate Beatty

Kate is a former Vice President, Enterprise Strategy & Planning at the Center for Creative Leadership. Prior to joining CCL, Kate was an associate with Colarelli, Meyer & Associates, Inc. (CMA), a consulting firm based in the Midwestern United States. There, she focused on organizational...

Hany Farid

Current Research Topics Developing new tools for authenticating digital images and video Deciphering extremely low-resolution images Distinguishing between computer-generated and photographic images Professional Activities Academic positions Adjunct Professor of Business Administration, Tuc...

Leah Weiss

Research Statement Leah is a contemplative scholar and writer specializing in the application of meditation in secular contexts. She leads courses on compassionate leadership at the Stanford Graduate School of Business and is Principal Teacher and Trainer for Stanford’s Compassion Cultivation Pro...

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.